Cas:54581-69-0 1,4-Diazabicyclo[2.2.2]octane Dihydrobromide manufacturer & supplier

Chemical Name:1,4-Diazabicyclo[2.2.2]octane Dihydrobromide

CAS.NO:54581-69-0

Synonyms:1,4-Diazabicyclo[2.2.2]octane, hydrobromide (1:2);1,4-Diazabicyclo[2.2.2]octane dihydrobromide

Molecular Formula:C₆H₁₄Br₂N₂

Molecular Weight:273.997

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:271.952362

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4-Diazabicyclo[2.2.2]octane, hydrobromide (1:2) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Diazabicyclo[2.2.2]octane dihydrobromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Diazabicyclo[2.2.2]octane, hydrobromide (1:2) Use and application,1,4-Diazabicyclo[2.2.2]octane, hydrobromide (1:2) technical grade,usp/ep/jp grade.

Related News: The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 1,4-Diazabicyclo[2.2.2]octane Dihydrobromide manufacturer Matthew Cheung, Hong Kong��s No. 2 official, appealed to medical workers to reconsider. ��At this critical moment, I believe the general public would count on medical personnel to fight against the epidemic together, in the spirit of professionalism,�� he wrote in a blog post on Sunday. 1,4-Diazabicyclo[2.2.2]octane Dihydrobromide supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 1,4-Diazabicyclo[2.2.2]octane Dihydrobromide vendor A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported. 1,4-Diazabicyclo[2.2.2]octane Dihydrobromide factory It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering.